Frontlight ResearchEarly access
Trial site
IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola Malpighi
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer2 trials
- Myeloproliferative neoplasms2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Heart failure1 trial
- IgA nephropathy1 trial
- Liver and biliary tract cancer1 trial
- Polycystic kidney disease1 trial
- Phase
- Phase 24 trials
- Phase 1/22 trials
- Phase 32 trials
- Phase 41 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed2 trials
- Not yet recruiting2 trials
- Lead sponsor
- AbbVie1 trial
- Fondazione Schena1 trial
- Gruppo Oncologico Del Nord Ovest1 trial
- Ionis Pharmaceuticals, Inc.1 trial
- Iperboreal Pharma Srl1 trial
- and 4 more
Running trials
Recruiting
Pembrolizumab Plus Lenvatinib in Vulvar Cancer Patients: MITO VULVA-01
Recruiting
Recruiting
Active, not recruiting
Recruiting
Not yet recruiting
Active, not recruiting
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Heart failure1 recruiting
- IgA nephropathy1 recruiting
- Polycystic kidney disease1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026